U.S., May 9 -- ClinicalTrials.gov registry received information related to the study (NCT06962033) titled 'PRIDE III Prison Interventions and HIV Prevention Collaboration' on April 29.
Brief Summary: The primary objective of this research project is to identify barriers to scale-up of Opioid Agonist Therapy (OAT) in the justice systems (prisons and probation) in Tajikistan, Kyrgyzstan, Moldova, and Georgia, and establish a NIATx learning collaborative to scale-up OAT, and analyze scale-up utilizing latent class growth analyses in people who inject drugs (PWID).
Study Start Date: June, 2025
Study Type: INTERVENTIONAL
Condition:
Hiv
Opioid Use
Intervention:
BEHAVIORAL: Opioid Agonist Therapy
Opioid Agonist Therapy (OAT) as HIV prevent...